MNKD
MannKind Corp
3.30$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +48.3% | +1.2% | -7.7% | +4.6% | -15.2% | +4.1% | +0.4% | +20.1% | +60.2% | -6.0% | -1.6% | |
| – | +65.5% | +2.6% | -14.9% | +0.5% | -18.1% | +2.0% | +1.9% | +28.6% | -18.7% | -13.9% | -2.2% | |
| – | +187.3% | -19.0% | -50.0% | -35.5% | -25.7% | +2.1% | +20.5% | +123.5% | -41.2% | -29.4% | +0.2% | |
| – | +109.3% | +1.9% | -17.6% | +1.5% | -21.6% | -8.0% | -1.4% | +45.3% | -34.1% | -21.9% | -17.0% | |
| – | -31.7% | +33.6% | +17.2% | -22.1% | -35.1% | +144.8% | -6.1% | -30.4% | +103.2% | -25.1% | +50.4% | |
| – | +5.3% | -7.4% | -6.4% | +7.7% | +4.6% | +3.6% | -1.4% | -5.3% | +30.9% | +39.2% | -9.7% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3,400.5% | +0.0% | +0.0% | |
| – | -1.8% | -1.9% | -1.9% | +414.3% | -0.9% | -0.9% | -0.9% | -0.9% | -0.9% | +6,215.7% | -1.4% | |
| – | +26.1% | -1.5% | -5.8% | +0.7% | -29.9% | -0.8% | -0.4% | +15.5% | +56.4% | -4.7% | -0.5% | |
| – | +8.0% | -4.1% | -19.9% | -9.9% | +13.5% | +41.7% | -3.5% | -2.4% | +56.7% | -21.3% | +6.2% | |
| – | +0.0% | +0.0% | -34.5% | – | – | +175.1% | +0.2% | +35.4% | +0.6% | -73.8% | -83.9% | |
| – | -42.8% | -25.4% | +33.7% | -32.6% | +5.4% | -25.8% | +103.5% | -29.1% | +24.3% | +78.7% | -31.6% | |
| – | -1.8% | -1.8% | -6.8% | +0.2% | -84.2% | – | – | – | +333.6% | +0.1% | +0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.5% | +0.3% | -15.9% | +4.3% | +2.1% | +10.4% | -2.9% | +0.0% | +0.8% | -1.9% | +0.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.